{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:34:32Z","timestamp":1784122472797,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"DOI":"10.7759\/cureus.72089","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:51:17Z","timestamp":1729583477000},"source":"Crossref","is-referenced-by-count":3,"title":["Probiotic Potential in Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Comprehensive Systematic Review"],"prefix":"10.7759","author":[{"given":"Anura","family":"Manandhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala  A","family":"Abdelhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adoum","family":"Oumar Abakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Reddy","family":"Gangavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed  A","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iana","family":"Malasevskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104408","article-title":"Irritable bowel syndrome in adults: prevalence and risk factors","volume":"81","author":"Zeeshan MH","year":"2022","unstructured":"Zeeshan MH, Vakkalagadda NP, Sree GS, et al.. Irritable bowel syndrome in adults: prevalence and risk factors. Ann Med Surg (Lond). 2022, 81:104408. 10.1016\/j.amsu.2022.104408","journal-title":"Ann Med Surg (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15403\/jgld-3936","article-title":"Probiotics in the treatment of inflammatory bowel disease in adulthood: a systematic review","volume":"31","author":"Lorentz A","year":"2022","unstructured":"Lorentz A, M\u00fcller L. Probiotics in the treatment of inflammatory bowel disease in adulthood: a systematic review. J Gastrointestin Liver Dis. 2022, 31:74-84. 10.15403\/jgld-3936","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins L","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al.. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012, 491:119-24. 10.1038\/nature11582","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford AC","year":"2014","unstructured":"Ford AC, Moayyedi P, Lacy BE, et al.. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014, 109:2-26. 10.1038\/ajg.2014.187","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14422","article-title":"Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis","volume":"47","author":"Singh S","year":"2018","unstructured":"Singh S, Fumery M, Sandborn WJ, Murad MH. Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis. Aliment Pharmacol Ther. 2018, 47:162-175. 10.1111\/apt.14422","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill C","year":"2014","unstructured":"Hill C, Guarner F, Reid G, et al.. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014, 11:506-14. 10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref9","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells GA","year":"2000","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. 2000,","journal-title":"The Ottawa Hospital Research Institute"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2013.825314","article-title":"Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial","volume":"48","author":"Begtrup LM","year":"2013","unstructured":"Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarb\u00f8l DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol. 2013, 48:1127-35. 10.3109\/00365521.2013.825314","journal-title":"Scand J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i17.2067","article-title":"Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study","volume":"18","author":"Dapoigny M","year":"2012","unstructured":"Dapoigny M, Piche T, Ducrotte P, Lunaud B, Cardot JM, Bernalier-Donadille A. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study. World J Gastroenterol. 2012, 18:2067-75. 10.3748\/wjg.v18.i17.2067","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04633.x","article-title":"Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study","volume":"33","author":"Guglielmetti S","year":"2011","unstructured":"Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011, 33:1123-32. 10.1111\/j.1365-2036.2011.04633.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03362.x","article-title":"Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial","volume":"26","author":"Guyonnet D","year":"2007","unstructured":"Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 2007, 26:475-86. 10.1111\/j.1365-2036.2007.03362.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02579.x","article-title":"A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention","volume":"22","author":"Kajander K","year":"2005","unstructured":"Kajander K, Hatakka K, Poussa T, F\u00e4rkkil\u00e4 M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther. 2005, 22:387-94. 10.1111\/j.1365-2036.2005.02579.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-011-1363-9","article-title":"A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome","volume":"27","author":"Kruis W","year":"2012","unstructured":"Kruis W, Chrubasik S, Boehm S, Stange C, Schulze J. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int J Colorectal Dis. 2012, 27:467-74. 10.1007\/s00384-011-1363-9","journal-title":"Int J Colorectal Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-45","article-title":"A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome","volume":"13","author":"Roberts LM","year":"2013","unstructured":"Roberts LM, McCahon D, Holder R, Wilson S, Hobbs FD. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol. 2013, 13:45. 10.1186\/1471-230X-13-45","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04183.x","article-title":"Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome-a randomized, double-blind, controlled study","volume":"31","author":"Simr\u00e9n M","year":"2010","unstructured":"Simr\u00e9n M, Ohman L, Olsson J, Svensson U, Ohlson K, Posserud I, Strid H. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome-a randomized, double-blind, controlled study. Aliment Pharmacol Ther. 2010, 31:218-27. 10.1111\/j.1365-2036.2009.04183.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02268.x","article-title":"Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis","volume":"20","author":"Kato K","year":"2004","unstructured":"Kato K, Mizuno S, Umesaki Y, et al.. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004, 20:1133-41. 10.1111\/j.1365-2036.2004.02268.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/nu11091968","article-title":"Bacillus spp. spores-a promising treatment option for patients with irritable bowel syndrome","volume":"11","author":"Catinean A","year":"2019","unstructured":"Catinean A, Neag AM, Nita A, Buzea M, Buzoianu AD. Bacillus spp. spores-a promising treatment option for patients with irritable bowel syndrome. Nutrients. 2019, 11:1968. 10.3390\/nu11091968","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041159","article-title":"Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in alleviating symptoms of irritable bowel syndrome (IBS): a randomized, placebo-controlled study","volume":"12","author":"Lewis ED","year":"2020","unstructured":"Lewis ED, Antony JM, Crowley DC, Piano A, Bhardwaj R, Tompkins TA, Evans M. Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in alleviating symptoms of irritable bowel syndrome (IBS): a randomized, placebo-controlled study. Nutrients. 2020, 12:1159. 10.3390\/nu12041159","journal-title":"Nutrients"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8709","article-title":"I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life","volume":"20","author":"Lorenzo-Z\u00fa\u00f1iga V","year":"2014","unstructured":"Lorenzo-Z\u00fa\u00f1iga V, Llop E, Su\u00e1rez C, Alvarez B, Abreu L, Espadaler J, Serra J. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014, 20:8709-16. 10.3748\/wjg.v20.i26.8709","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020363","article-title":"Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 improve abdominal pain severity and symptomology in irritable bowel syndrome: randomized controlled trial","volume":"12","author":"Martoni CJ","year":"2020","unstructured":"Martoni CJ, Srivastava S, Leyer GJ. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 improve abdominal pain severity and symptomology in irritable bowel syndrome: randomized controlled trial. Nutrients. 2020, 12:363. 10.3390\/nu12020363","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.05.003","article-title":"Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome","volume":"153","author":"Pinto-Sanchez MI","year":"2017","unstructured":"Pinto-Sanchez MI, Hall GB, Ghajar K, et al.. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017, 153:448-459.e8. 10.1053\/j.gastro.2017.05.003","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i7.732","article-title":"Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome","volume":"28","author":"Sabat\u00e9 JM","year":"2022","unstructured":"Sabat\u00e9 JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol. 2022, 28:732-44. 10.3748\/wjg.v28.i7.732","journal-title":"World J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease","volume":"27","author":"Bjarnason I","year":"2019","unstructured":"Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. Inflammopharmacology. 2019, 27:465-73. 10.1007\/s10787-019-00595-4","journal-title":"Inflammopharmacology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-4946-2","article-title":"Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis","volume":"63","author":"Matsuoka K","year":"2018","unstructured":"Matsuoka K, Uemura Y, Kanai T, et al.. Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis. Dig Dis Sci. 2018, 63:1910-9. 10.1007\/s10620-018-4946-2","journal-title":"Dig Dis Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2020.0119","article-title":"Therapeutic potential of Escherichia coli Nissle 1917 in clinically remission-attained ulcerative colitis patients: a hospital-based cohort study","volume":"77","author":"Oh GM","year":"2021","unstructured":"Oh GM, Moon W, Seo KI, et al.. Therapeutic potential of Escherichia coli Nissle 1917 in clinically remission-attained ulcerative colitis patients: a hospital-based cohort study. Korean J Gastroenterol. 2021, 77:12-21. 10.4166\/kjg.2020.0119","journal-title":"Korean J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Y\u0131lmaz \u0130","year":"2019","unstructured":"Y\u0131lmaz \u0130, Dolar ME, \u00d6zp\u0131nar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol. 2019, 30:242-53. 10.5152\/tjg.2018.18227","journal-title":"Turk J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i19.5985","article-title":"Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis","volume":"21","author":"Yoshimatsu Y","year":"2015","unstructured":"Yoshimatsu Y, Yamada A, Furukawa R, et al.. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World J Gastroenterol. 2015, 21:5985-94. 10.3748\/wjg.v21.i19.5985","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173856","article-title":"Outcome-specific efficacy of different probiotic strains and mixtures in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"15","author":"Xie P","year":"2023","unstructured":"Xie P, Luo M, Deng X, Fan J, Xiong L. Outcome-specific efficacy of different probiotic strains and mixtures in irritable bowel syndrome: a systematic review and network meta-analysis. Nutrients. 2023, 15:3856. 10.3390\/nu15173856","journal-title":"Nutrients"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.859967","article-title":"Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis","volume":"12","author":"Zhang T","year":"2022","unstructured":"Zhang T, Zhang C, Zhang J, Sun F, Duan L. Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis. Front Cell Infect Microbiol. 2022, 12:859967. 10.3389\/fcimb.2022.859967","journal-title":"Front Cell Infect Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092048","article-title":"Probiotics in irritable bowel syndrome: an up-to-date systematic review","volume":"11","author":"Dale HF","year":"2019","unstructured":"Dale HF, Rasmussen SH, Asiller \u00d6\u00d6, Lied GA. Probiotics in irritable bowel syndrome: an up-to-date systematic review. Nutrients. 2019, 11:2048. 10.3390\/nu11092048","journal-title":"Nutrients"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.0923","article-title":"P793 efficacy and safety of probiotics in inflammatory bowel disease: an umbrella review and updated meta-analysis of randomized controlled trials","volume":"18","author":"Estevinho MM","year":"2024","unstructured":"Estevinho MM, Rodriguez-Lago I, Dias CC, Barreiro-de Acosta M, Magro F. P793 efficacy and safety of probiotics in inflammatory bowel disease: an umbrella review and updated meta-analysis of randomized controlled trials. J Crohns Colitis. 2024, 18:i1482. 10.1093\/ecco-jcc\/jjad212.0923","journal-title":"J Crohns Colitis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006634.pub3","article-title":"Probiotics for induction of remission in Crohn's disease","volume":"7","author":"Limketkai BN","year":"2020","unstructured":"Limketkai BN, Akobeng AK, Gordon M, Adepoju AA. Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2020, 7:CD006634. 10.1002\/14651858.CD006634.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx002.746","article-title":"P622 efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis","volume":"11","author":"Derwa Y","year":"2017","unstructured":"Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. P622 efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis. J Crohns Colitis. 2017, 11:S398-9. 10.1093\/ecco-jcc\/jjx002.746","journal-title":"J Crohns Colitis"},{"key":"ref36","article-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JPT","year":"2023","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions. 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282474-probiotic-potential-in-irritable-bowel-syndrome-and-inflammatory-bowel-disease-a-comprehensive-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:51:19Z","timestamp":1729583479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282474-probiotic-potential-in-irritable-bowel-syndrome-and-inflammatory-bowel-disease-a-comprehensive-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.72089","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,22]]}}}